Login
$HSCT
$0.39 +$0.00 (0.0%) Close

Balance Sheets

In USD, except per-share amounts
Q4 FY2026
As of Jun 30, 2026
Q3 FY2026
As of Mar 31, 2026
Q2 FY2026
As of Dec 31, 2025
Q1 FY2026
As of Sep 30, 2025
Q4 FY2025
As of Jun 30, 2025
Q2 FY2025
As of Dec 31, 2024
Q3 FY2025
As of Mar 31, 2025
Q1 FY2025
As of Sep 30, 2024
Q4 FY2024
As of Jun 30, 2024
Q3 FY2024
As of Mar 31, 2024
Q2 FY2024
As of Dec 31, 2023
Q1 FY2024
As of Sep 30, 2023
Q4 FY2023
As of Jun 30, 2023
Q3 FY2023
As of Mar 31, 2023
Q2 FY2023
As of Dec 31, 2022
Q1 FY2023
As of Sep 30, 2022
Q4 FY2022
As of Jun 30, 2022
Q3 FY2022
As of Mar 31, 2022
Q2 FY2022
As of Dec 31, 2021
Q1 FY2022
As of Sep 30, 2021
Assets
Bank
Current assets
Bank
Bank
Cash
Inventory
Advances
Total current assets
Less: Amortization
Property and equipment net
Total assets
Current liabilities
Short term debts
Accounts payable and accrued liabilities
Accounts payable
Accrued liabilities
Due to related party (Note 3)
Loans payable (Note 7)
Total current liabilities
Loans payable (Note 7)
Total liabilities
Stockholders' deficit
Common stock Authorized: 10,000,000,000 common shares, $0.0001 par value 101,250,000 shares issued and outstanding as of June 30, 2026 and June 30, 2025 respectively
Additional paid-in capital
Accumulated deficit
Total stockholders' deficit
Total liabilities and stockholders' deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support